Lecture 04 - Pharmacokinetics and Pharmacodynamics Flashcards

1
Q

What are the four categories that effect metabolism of drugs

A
  • host factors (diet and disease states)
  • influence of genetics
  • enzyme induction
    -inhibition of CYP enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pharmacogenetics

A

the study of genetically determining variation in drug metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is pharmacogenomics

A

the customization of dosing to match a patients specific genetic profile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are polymorphisms

A

mutations that occur inn at least 1% of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do polymorphisms result in

A

decreased activity, increased activity, no activity, no change in activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an extensive metabolizer

A

a person who metabolizes a probe drug at a rate similar to that of most of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a poor metabolizer

A

a person who metabolizes a probe drug at a rate slower than most of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the therapeutic consequence of being a poor metabolizer

A

lack of response due to inability to convert pro drug to its active form or may result in high levels of parent drug causing toxic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is an ultra-rapid metabolizer

A

a person who metabolizes a drug more rapidly than most of the population due to the presence of multiple copies of the CYP2D6 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the therapeutic consequence of being an ultra-rapid metabolizer

A

these people fail to respond to conventional doses of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do we determine what kind of metabolizer someone is

A

genotyping (predict optimal dose using genetic info) or phenotyping (predict dose using drug ratio in urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is CYP2D6

A

accounts for 1-5% of total CYP, expressed in liver intestines kidney and brain, metabolizes 30% of drugs currently used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some common substrates of CYP2D6

A

codeine, fluoxetine, amitriptyline, paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is CYP2C9*1

A

the wildtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is CYP2C9*2

A

a mutation of A to C at position 144, results in reduced metabolism of warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is CYP2C9*3

A

a mutation of I to L at position 259, results in reduced metabolism of warfarin

17
Q

How does warfarin get effected by CYP2C9

A

if person has the poor metabolizer mutation they need a lower dose otherwise the S-isomer will build up and not be metabolized which can be dangerous

18
Q

What does enzyme induction do

A

can increase CYP enzyme expression by increase synthesis, decrease degradation, or activate pre-existing components of the metabolic system

19
Q

How does ethanol interact with acetaminophen

A

it induces CYP2E1 which increases metabolism of acetaminophen to NAPQI

20
Q

What is the double whammy with alcohol abuse and acetaminophen

A

often alcoholics are malnourished resulting in low glutathione stores

21
Q

What types of inhibitors are there from drugs to the CYP enzymes

A

competitive inhibition for active site between substrates, competitive inhibition of active site (non substrate), metabolic activation forming inhibitory products

22
Q

What does inhibition do

A

drug isn’t converted to active form which causes a decreased concentration below the therapeutic level

23
Q

What does induction do

A

the drug is metabolized at a higher rate causing an increased concentration and more risk of toxic side effects

24
Q

How can polymorphisms in NAT-2 gene effect drug metabolism

A

slow acetylators are unable to acetylate a range of drugs

25
Q

How can polymorphisms in NAT-2 gene modulate risk of cancer

A

it acetylates aromatic amines found in tobacco smoke and charred foods that can induce cancers

26
Q

What is cyclosproine

A

a first line immunosuppressant that has revolutionized the field of organ transplants and reduced acute rejection rates

27
Q

Where is cyclosporine found

A

a cyclic peptide of 11 amino acids from the fungus tolypocladium inflatum

28
Q

How does cyclosporine work

A

it inhibits calcineurin through cyclophilin to block NDAT-mediated transcription of IL-2

29
Q

What is sirolimus

A

used in place of and in combination with cyclosporine or tacrolimus

30
Q

How does sirolimus work

A

binds FKBP12 and the complex inhibits mTOR and blocks signalling downstream of IL-2 which inhibits IL-2-mediated activation of T and B cells

31
Q

What is the first line immunosuppressant drug used in the IS

A

tacrolimus

32
Q

How does tacrolimus work

A

it is a clacineurin inhibitor 100x more potent than cyclosporine

33
Q

What factors effect appropriate dosing for transplants

A

organ type, kidney function, diet, time after transplant, protein binding, metabolism, route of administration, drug formulation